Determination of chlorine and bromine in automotive shredder residues by oxygen bomb and ion chromatography
An analytical procedure, oxygen bomb combustion-ion chromatography (IC), has been developed for the determination of total chlorine in Automotive Shredder Residues (ASR). Samples of these residues are fired under elevated oxygen pressure (30 atm) and the combustion products are transferred into a Na2 CO3/NaHCO3 absorbent solution containing 1% of H2 O2; the chlorine contents are then evaluated by ion chromatography. The use of the non-suppressed IC determination with a conductivity detector provides a rapid, sensitive and selective method for chlorine determination in ASR, allowing determinations of this heteroatom at levels below 1% in the presence of bromine and sulfur. Moreover, the proposed method allows the simultaneous determination of chlorine, bromine and sulfur which are potential environmental hazards.
Analyse de la teneur en fluor, en chlore, en brome et en soufre après minéralisation par combustion : Analyse de l'eau
Le present article decrit un procede d'analyse en parallele des teneurs en F, CI, Br et S de matieres combustibles, ainsi que de leur pouvoir ou de leur valeur calorifique. Le principe de l'analyse repose sur la destruction complete de la matrice organique des echantillons par combustion dans une bombe de mineralisation calorimetrique sous une pression d'oxygene partielle de 30 bars. Les composes organiques halogenes et sulfures sont ainsi transformes respectivement en halogenures ou en SO 3 . Apres adsorption quantitative de tous les produits de la combustion dans une matrice aqueuse, on mesure les teneurs en halogenures et en sulfates par chromatographie ionique. L'ensemble du procede dure entre 20 et 30 minutes et fournit des resultats aisement reproductibles. Les limites de detection des differents elements sont respectivement inferieurs a 0,01 % en poids.
Antitumor activities of (2"R)-4'-O-tetrahydropyranyl-adriamycin (THP) and its combination with other antitumor agents on murine tumors.
(2''R)-4'-O-Tetrahydropyranyladriamycin (THP) is a new derivative of doxorubicin (adriamycin, ADM). The concentrations of THP and ADM required to inhibit by 50% the growth of a cultured L1210 cells was 0.003 microgram/ml and 0.016 microgram/ml, respectively. Various therapeutic designs of combinations of THP with other antitumor agents were investigated in vivo using the L1210 murine leukemia. The combination of THP with cytosine arabinoside (Ara-C), cyclocytidine hydrochloride (Cyclo-C), 6-mercaptopurine (6-MP) and cyclophosphamide (EX) showed a great effectiveness following daily intraperitoneal treatment from days 1 to 10. High therapeutic effects were also obtained with the combinations of THP with Ara-C, Cyclo-C, vincristine (VCR) and EX following intravenous combination therapy one day following implantation of L1210 leukemia. Schedule dependency and its therapeutic efficacy of THP were examined. THP showed almost the same antitumor activity on the solid-type sarcoma-180 or solid-type Ehrlich carcinoma as ADM by intraperitoneal or intravenous treatment. THP showed some superior activity to ADM in the advanced stage of L1210 leukemia. High antitumor activity of THP on murine leukemia L1210 has been reported by Tsuruo et al. (Cancer Res. 42: 1462-1467, 1982) and was also confirmed. THP gave many mice cures, especially in the intravenous treatment.